πŸ‡ΊπŸ‡Έ FDA
Patent

US 9732110

Nucleoside and nucleotide derivatives

granted A61KA61K31/7052A61K31/706

Quick answer

US patent 9732110 (Nucleoside and nucleotide derivatives) held by Enanta Pharmaceuticals, Inc. expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Enanta Pharmaceuticals, Inc.
Grant date
Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/7052, A61K31/706, A61K31/7064, A61K31/7068